| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,314 | 39,465 | 38,831 | 45,058 | | Cost of Revenue | 13,129 | 13,637 | 13,696 | 14,854 | | | Gross Profit | 27,185 | 25,828 | 25,135 | 30,204 | | | Operating Expenses | | Research Development | 2,453 | 2,536 | 2,568 | 2,950 | | Selling General and Administrative | 19,265 | 18,158 | 19,578 | 21,002 | | Non Recurring |
-
|
-
| 33,329 | 168,990 | | Others | 3,582 | 3,274 | 3,228 | 3,322 | | | | Total Operating Expenses |
-
|
-
| 58,703 | 196,264 | | | | Operating Income or Loss | 1,885 | 1,860 | (33,568) | (166,060) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 102 | 184 | (232) | 179 | | Earnings Before Interest And Taxes | 1,801 | 2,044 | (33,800) | (165,881) | | Interest Expense | (158) | 158 |
-
|
-
| | Income Before Tax | 1,959 | 1,886 | (33,800) | (165,881) | | Income Tax Expense | 361 | 575 | 482 | (45,026) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,598 | 1,311 | (34,282) | (120,855) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,598 | 1,311 | (34,282) | (120,855) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,598 | $1,311 | ($34,282) | ($120,855) |
|
0.63% Nasdaq 
0.03%
Income Statement
